Table I.
Patient | Gender | Age | Diagnosis | Treatment history | Other vascular malformations |
---|---|---|---|---|---|
1 | M | 22 mo | PWS face | PDL | No |
2 | F | 9 mo | PWS arm | None | No |
3 | M | 41 y | PWS face | PDL | No |
4 | M | 38 y | PWS face | PDL | No |
5 | M | 38 y | PWS arm | PDL | No |
6 | F | 56 y | PWS face | PDL | No |
7 | M | 51 y | PWS face | None | No |
8 | F | 13 y | PWS face | PDL | No |
9 | F | 16 y | PWS face | None | No |
10 | M | 27 y | PWS face | None | No |
11 | M | 55 y | PWS face | None | No |
12 | M | 6 mo | Proliferative hemangioma | Steroid, PDL | No |
13 | F | 6 mo | Proliferative hemangioma | Topical antibiotics for ulceration | Yes |
14 | F | 4 y | Involuting hemangioma | None | No |
15 | F | 2 y | Involuting hemangioma | None | Yes |
16 | F | 2 y | Involuting hemangioma | Topical beta-blockers | No |
17 | M | 8 mo | Proliferative hemangioma | Topical antibiotics for ulceration | No |
18 | F | 12 mo | Involuting hemangioma | None | Yes |
19 | F | 1 y | Involuting hemangioma | None | Yes |
20 | F | 3 y | Involuting hemangioma | None | No |
F, Female; M, male; PDL, pulsed dye laser; PWS, port-wine stain.